NASDAQ
Innate Pharma S.A. (IPHYF) has a free cash flow growth of 30.61% as of Friday, May 29, 2026. This represents a 119.07% increase compared to its 12-month average of -160.53%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.